Rab Prinjha

Direttore/Membro del Consiglio presso Padlock Therapeutics, Inc.

Health Technology

Consumer Services

Posizioni attive di Rab Prinjha

Società	Posizione	Inizio	Fine
Padlock Therapeutics, Inc. Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA.	Direttore/Membro del Consiglio	-	-

Società	Posizione	Inizio	Fine
GSK PLC	Corporate Officer/Principal	-	-

University College London

Doctorate Degree

Distribuzione geografica

Regno Unito	3
Stati Uniti	2

Posizioni

Director/Board Member	1
Doctorate Degree	1
Corporate Officer/Principal	1

Settori

Health Technology	3
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
GSK PLC	Health Technology

Aziende private	1
Padlock Therapeutics, Inc. Padlock Therapeutics, Inc. BiotechnologyHealth Technology Padlock Therapeutics, Inc. develops medicines targeting protein-arginine deiminases. It develops drugs that block the protein-arginine deiminase (PAD) enzymes. The firm leverages the breakthrough science on the role of protein citrullination in disease to develop drugs targeting protein-arginine deiminase (PAD) enzymes. The company was founded by Paul Thompson, Kerri Mowen, Todd A. Huffman and Michael Gilman in January 2014 and is headquartered in Cambridge, MA.	Health Technology

Aziende private

Health Technology